Analytical Data
-
基因名
SAA
- Application
-
别名
SAA；Serum amyloid A-1 Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0DJI8
-
表达区间
19-122aa
-
氨基酸序列
RSFFSFLGEA FDGARDMWRA YSDMREANYI GSDKYFHARG NYDAAKRGPG GVWAAEAISD ARENIQRFFG HGAEDSLADQ AANEWGRSGK DPNHFRPAGL PEKY
-
分子量
11.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAA (serum amyloid A) proteins are a group of acute-phase reactants primarily produced by the liver in response to inflammation. Elevation of SAA levels is associated with various diseases, including rheumatoid arthritis, inflammatory bowel disease, and cardiovascular disorders, making it an important biomarker for inflammatory conditions. Research into SAA has garnered attention due to its role in the pathogenesis of amyloidosis, where misfolded SAA proteins aggregate and form amyloid fibrils, leading to tissue damage. The study of recombinant SAA proteins has advanced our understanding of their structure, function, and interactions with other molecules in the immune system. By employing recombinant DNA technology, researchers can produce specific SAA isoforms to investigate their biological activities, establish their role in disease processes, and explore their potential as therapeutic targets or biomarkers. Additionally, recombinant SAA proteins facilitate the development of diagnostic assays, contributing to early detection and personalized treatment strategies. Overall, the research on SAA recombinant proteins holds significant promise for elucidating the complexities of inflammatory diseases and improving clinical outcomes.
